Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Eli Lilly Corp. buy Traumtanz

Start price
€388.00
05.05.23 / 50%
Target price
€395.00
05.05.24
Performance (%)
3.52%
End price
€400.60
12.05.23
Summary
This prediction ended on 12.05.23 with a price of €400.60. With a performance of 3.52%, the BUY prediction by Traumtanz for Eli Lilly Corp. closed with a slight gain. A total of €1.04 was paid as dividends for this prediction. Traumtanz has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Eli Lilly Corp. 0.087% 0.087%
iShares Core DAX® 0.961% -2.210%
iShares Nasdaq 100 2.626% -1.918%
iShares Nikkei 225® 0.217% -7.216%
iShares S&P 500 1.540% -1.858%

According to Traumtanz what are the pros and cons of Eli Lilly Corp. for the foreseeable future?

Pros
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Valuable balance sheet
ROE higher than 10% per year
Normal challenges to pay loans and raise capital
Good culture
Innovative
Some uniques
Growths faster than the competition
Sustainability is important
Stable Large shareholder and/or long term investor
Small cyclical dependencies
Known brand
Future proof or reliable business model
Cons

Comments by Traumtanz for this prediction

In the thread Eli Lilly Corp. diskutieren
Prediction Buy
Perf. (%) 3.52%
Target price 395.000
Change
Ends at

Buy mit Kursziel 395,0

In the thread Trading Eli Lilly Corp.
Prediction Buy
Perf. (%) 3.52%
Target price 395.000
Change
Ends at 05.05.24

Buy beendet

Stopped prediction by Traumtanz for Eli Lilly Corp.

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€529.00
18.12.23
€558.00
18.12.24
6.62%
06.01.24

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€526.00
14.12.23
€558.00
14.12.24
0.57%
18.12.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€568.50
11.10.23
€558.00
11.10.24
-7.48%
14.12.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€533.50
19.09.23
€558.00
19.09.24
6.56%
11.10.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€555.50
15.09.23
€558.00
15.09.24
-3.96%
19.09.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€502.50
17.08.23
€510.00
17.08.24
10.75%
13.09.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€362.80
29.10.22
€400.00
29.10.23
6.95%
05.05.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€338.70
07.10.22
€350.00
07.10.23
7.12%
29.10.22

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€125.04
16.10.20
€120.00
04.11.21
4.56%
09.12.20

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€126.00
14.10.20
€120.00
16.10.20
-0.76%
16.10.20

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€134.00
07.04.20
€175.00
10.06.20
-0.91%
10.06.20

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€106.50
24.01.19
€126.28
28.01.19
-3.53%
28.01.19

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€99.33
19.12.18
€126.28
07.01.19
2.04%
07.01.19

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market